RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Return
24.59%
This Quarter Return
+4.64%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$106B
AUM Growth
+$2.27B
(+2.2%)
Cap. Flow
-$487M
Cap. Flow
% of AUM
-0.46%
Top 10 Holdings %
Top 10 Hldgs %
30.07%
Holding
4,480
New
178
Increased
2,059
Reduced
1,848
Closed
61
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$99.6M |
| 2 |
GE Vernova
GEV
|
+$81.6M |
| 3 |
CrowdStrike
CRWD
|
+$52.8M |
| 4 |
CRH
CRH
|
+$45.6M |
| 5 |
Dell
DELL
|
+$36.8M |
Top Sells
| 1 |
iShares Russell 1000 ETF
IWB
|
+$186M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$121M |
| 3 |
GE Aerospace
GE
|
+$58.8M |
| 4 |
UnitedHealth
UNH
|
+$48.4M |
| 5 |
NVIDIA
NVDA
|
+$46.8M |
Sector Composition
| 1 | Technology | 31% |
| 2 | Financials | 12.54% |
| 3 | Healthcare | 11.47% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Trinseo
TSE
$81.6M
| $42.5K | ﹤0.01% |
18,409
-36,464
| -66% | -$84.2K |
|
3377
Southland Holdings
SLND
$227M
| $42.2K | ﹤0.01% |
9,209
+5,122
| +125% | +$23.5K |
|
3378
Sibanye-Stillwater
SBSW
$6.11B
| $42.1K | ﹤0.01% |
9,670
| – | – |
|
|
NNDM
3379
Nano Dimension
NNDM
$311M
| $42K | ﹤0.01% |
19,113
+2,479
| +15% | +$5.45K |
|
3380
Levi Strauss
LEVI
$8.59B
| $41.8K | ﹤0.01% |
2,166
| – | – |
|
3381
Vuzix
VUZI
$176M
| $41.5K | ﹤0.01% |
30,747
-61,283
| -67% | -$82.7K |
|
|
EVBN
3382
DELISTED
Evans Bancorp Inc
EVBN
| $40.7K | ﹤0.01% |
1,447
-5,299
| -79% | -$149K |
|
|
EGRX
3383
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $40.6K | ﹤0.01% |
7,246
-9,920
| -58% | -$55.6K |
|
|
XNET
3384
Xunlei
XNET
$454M
| $40.5K | ﹤0.01% |
24,097
+7,220
| +43% | +$12.1K |
|
|
EH
3385
EHang Holdings
EH
$1.13B
| $40.4K | ﹤0.01% |
2,978
-180
| -6% | -$2.44K |
|
3386
System1
SST
$65.2M
| $39.9K | ﹤0.01% |
2,628
-435
| -14% | -$6.61K |
|
3387
Seres Therapeutics
MCRB
$154M
| $39.9K | ﹤0.01% |
2,756
-4,317
| -61% | -$62.5K |
|
3388
iShares MSCI Norway ETF
ENOR
$41.8M
| $39.8K | ﹤0.01% |
1,630
| – | – |
|
|
CANF
3389
Can-Fite BioPharma
CANF
$10.3M
| $39.7K | ﹤0.01% |
15,398
-3,084
| -17% | -$7.96K |
|
|
EM
3390
Smart Share Global Ltd
EM
$345M
| $39.2K | ﹤0.01% |
46,105
-16,515
| -26% | -$14K |
|
3391
Zai Lab
ZLAB
$3.16B
| $39.1K | ﹤0.01% |
2,255
-177
| -7% | -$3.07K |
|
3392
Roadzen
RDZN
$74.5M
| $38.9K | ﹤0.01% |
+17,511
| New | +$38.9K |
|
|
JMIA
3393
Jumia Technologies
JMIA
$1.09B
| $38.9K | ﹤0.01% |
5,535
-197
| -3% | -$1.38K |
|
3394
Open Text
OTEX
$8.93B
| $38.7K | ﹤0.01% |
1,290
-760
| -37% | -$22.8K |
|
|
ELUX
3395
DELISTED
AKTIEB. ELECTROLUX B ADR SPNSD
ELUX
| $38.3K | ﹤0.01% |
2,333
-370
| -14% | -$6.08K |
|
3396
Veritone
VERI
$201M
| $38.2K | ﹤0.01% |
16,894
-25,432
| -60% | -$57.5K |
|
|
ALLK
3397
DELISTED
Allakos
ALLK
| $38.1K | ﹤0.01% |
38,096
-65,442
| -63% | -$65.4K |
|
|
XYF
3398
X Financial
XYF
$561M
| $37.7K | ﹤0.01% |
8,745
| – | – |
|
|
MACK
3399
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $37.5K | ﹤0.01% |
2,480
-11,039
| -82% | -$167K |
|
3400
PMV Pharmaceuticals
PMVP
$67.3M
| $37.3K | ﹤0.01% |
23,035
-39,693
| -63% | -$64.3K |
|